Intervention

tirapazamine

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials5
Recruiting0
Common conditions2
Lead sponsors shown4
Advertisement

Clinical trials

5 shown
Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung CancerNCT00066742 · 2003-09-01
COMPLETED
Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerNCT00033410 · 2002-03-01
COMPLETED
Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerNCT00006484 · 2000-11-01
COMPLETED
S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung CancerNCT00006487 · 2000-10-01
COMPLETED
Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00017459 · 2000-07-01
COMPLETED

Trial status mix

COMPLETED5

Phase mix

PHASE12
PHASE32
PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.